Pharmaceutical compositions comprising phosphatidyl carnitine fo

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 78, A61K 31685

Patent

active

051359219

ABSTRACT:
We describe the use of phospholipidic carnitine derivatives of general formula ##STR1## in their racemic or optically active form, wherein R.sub.1 and R.sub.2, equal or different, are radicals of linear or branched, saturated or monoor poly-unsaturated, aliphatic acids with 1 to 20 C for the preparation of pharmaceutical compositions having an activity as reproductive agent of the nerve fibers in the therapy of human pathologies associated with neuronal damages, more particularly in the therapy of peripheral neuropathies, of cerebrovascular diseases, of cerebral level traumas and of chronic neurodegenerative diseases.

REFERENCES:
patent: 4343816 (1982-08-01), Cavazza
patent: 4346107 (1982-08-01), Cavazza et al.
patent: 4439438 (1984-03-01), Cavazza
Hintze, V et al. Lipids 10(1): 20-24 (1975).
Curti, D et al. Biological Psychiatry (1985).
Tempesta, JL Int. J. Clin. Pharm. Res. 3(4): 295-306 (1983).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions comprising phosphatidyl carnitine fo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising phosphatidyl carnitine fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising phosphatidyl carnitine fo will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-778429

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.